Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tatiana V. Shamova"'
Autor:
Tatiana V. Ausheva, Inna Arnoldovna Novikova, L.N. Vaschenko, Oleg I. Kit, E. Yu. Zlatnik, Anastasia O. Sitkovskaya, Emma E. Kechedzhieva, Tatiana V. Shamova, Elena S. Bondarenko, Irina R. Dashkova
Publikováno v:
Cell and Tissue Biology. 15:455-464
In this work we studied the effect of different concentrations of interleukin-2 (IL-2) and interferon-γ (IFN-γ) on the proliferation and immunophenotype of lymphocytes obtained from patients with locally advanced breast cancer (stage II-III) after
Autor:
Eduard E. Rostorguev, Irina V. Mezhevova, D. Yu. Gvaldin, Tatiana V. Shamova, Natalya N. Timoshkina, Sofia V. Timofeeva, Anastasia O. Sitkovskaya, S. Yu. Filippova
Publikováno v:
Crimea Journal of Experimental and Clinical Medicine. 10:39-42
Glial tumors, in particular those composed of astrocytes, are the most common group of primary brain tumors. The most common glial tumor is astrocytoma. The biology of glial tumors was routinely studied on immortalized cell lines. However, multiple p
Autor:
Sofia V. Timofeeva, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Inna A. Novikova, Elena Yu Zlatnik, Yaroslav S. Enin, Oleg N. Burov, Dmitry A. Kharagezov, Oleg N. Stateshny, Anton G. Milakin, Igor A. Leyman, Ellada A. Mirzoyan, Madina A. Gappoeva, Victoria N. Vitkovskaya, Kristian D. Iozefi, Yuriy N. Lazutin
Publikováno v:
Journal of Clinical Oncology. 40:e15079-e15079
e15079 Background: Initially, berberine was used as an antimicrobial agent in traditional medicine, but its anticancer properties were later discovered. In addition to its cytotoxic effect, berberine also has the ability to inhibit cell motility, whi
Autor:
Irina V. Mezhevova, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Yaroslav S. Enin, Oleg N. Burov, Elena Yu Zlatnik, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Sergey V. Tumanyan, Nina M. Abdullaeva, Anna A. Cherkasova, Polina A. Kruze, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15078-e15078
e15078 Background: It is known that berberine inhibits oxidative phosphorylation by suppressing respiratory complex I function, but the exact mechanism of this phenomenon has not yet been described. The aim of the study was to evaluate the effect of
Autor:
Sofia V. Timofeeva, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Inna A. Novikova, Yaroslav S. Enin, Oleg N. Burov, Elena Yu Zlatnik, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Oksana E. Zhenilo, Yuriy A. Poryvaev, Tatiana Yu. Myagkova, Viktoria V. Pozdnyakova, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15077-e15077
e15077 Background: Plant metabolites are traditionally a valuable source of anticancer drugs. The huge variety of molecular structures found in plants makes it possible to isolate substances that possess not only antimitotic, but also anti-migratory
Autor:
Svetlana Yu Filippova, Oleg I. Kit, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Sergey V. Tumanyan, Nina M. Abdullaeva, Oksana E. Zhenilo, Olga G. Selezneva, Natalia V. Chernikova, Anna Yu Ardzha, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15003-e15003
e15003 Background: Taxanes and platinum compounds are widely used in cervical cancer chemotherapy. In particular, a combination of 75 mg/m2cisplatin and 175 mg/m2 paclitaxel, which suggests a doses ratio of 1:2.3, is recommended as first-line systemi
Autor:
Anastasia O. Sitkovskaya, Oleg I. Kit, Svetlana Yu Filippova, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Anna A. Cherkasova, Polina A. Kruze, Yuriy A. Poryvaev, Natalia V. Chernikova, Olga G. Selezneva, Meri L. Adamyan, Olga N. Guskova
Publikováno v:
Journal of Clinical Oncology. 40:e15002-e15002
e15002 Background: Bleomycin is a glycopeptide antibiotic with anticancer properties. Clinical data indicate a relatively low efficacy of bleomycin in mono regimen, which is also accompanied by side effects from high doses. That’s why so it is more
Autor:
Svetlana Yu Filippova, Oleg I. Kit, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Tatiana O. Lapteva, Larisa N. Vashchenko, Emma E. Kechedzhieva, Irina R. Dashkova, Tatiana V. Ausheva, Elena А. Andreiko, Viktoria V. Pozdnyakova
Publikováno v:
Journal of Clinical Oncology. 40:e15067-e15067
e15067 Background: Biogels based on natural components of the extracellular matrix are traditionally used to obtain 3D models of breast cancer (BC) tumor growth. However, such biogels are difficult to use in 3D bioprinting due to their poor shape ret
Autor:
Anastasia O. Sitkovskaya, Oleg I. Kit, Svetlana Yu Filippova, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Elena Yu Zlatnik, Elena S. Bondarenko, Elena P. Kolpakova, Larisa N. Vashchenko, Emma E. Kechedzhieva, Irina R. Dashkova, Tatiana V. Ausheva, Elena А. Andreiko
Publikováno v:
Journal of Clinical Oncology. 40:e14539-e14539
e14539 Background: Promising oncolytic viruses are evaluated, as a rule, by their direct cytotoxic effect on cancer cells. However, the positive effect of cancer virotherapy may be associated with an effect on the immune system, in particular, on the
Autor:
Nadezhda V. Gnennaya, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Irina B. Lysenko, Nadezhda V. Nikolaeva, Natalia Yu. Samaneva, Yakha S. Gaysultanova, Inna A. Kamaeva, Anna V. Tishina, Tatiana F. Pushkareva, Elena A. Kapuza
Publikováno v:
Journal of Clinical Oncology. 40:e15009-e15009
e15009 Background: Multiple myeloma (MM) is a B-cell malignancy resulting from the abnormal proliferation of neoplastic plasma cells that produce monoclonal immunoglobulin (Ig). The high variability of the course of this disease, its genetic clonal h